Anaplastic thyroid cancer, tumorigenesis and therapy
- 7 August 2009
- journal article
- review article
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 179 (1) , 9-15
Abstract
Anaplastic thyroid cancer (ATC) is a fatal endocrine malignancy. Current therapy fails to significantly improve survival. Recent insights into thyroid tumorigenesis, post-malignant dedifferentiation and mode of metastatic activity offer new therapeutic strategies.Keywords
This publication has 54 references indexed in Scilit:
- Anaplastic thyroid carcinoma: clinical outcome of 30 consecutive patients referred to a single institution in the past 5 yearsEuropean Journal of Endocrinology, 2007
- Prognostic factors for Korean patients with anaplastic thyroid carcinomaHead & Neck, 2007
- Patterns of expression of cell cycle/apoptosis genes along the spectrum of thyroid carcinoma progressionSurgery, 2006
- Effect of all-trans retinoic acid on sodium/iodide symporter expression, radioiodine uptake and gene expression profiles in a human anaplastic thyroid carcinoma cell lineNuclear Medicine and Biology, 2006
- Expression of Aurora kinases in human thyroid carcinoma cell lines and tissuesInternational Journal of Cancer, 2006
- Anaplastic Thyroid Carcinoma: Biology, Pathogenesis, Prognostic Factors, and Treatment ApproachesAnnals of Surgical Oncology, 2006
- Cetuximab and Irinotecan Interact Synergistically to Inhibit the Growth of Orthotopic Anaplastic Thyroid Carcinoma Xenografts in Nude MiceClinical Cancer Research, 2006
- Anaplastic thyroid carcinomaCancer, 2005
- Structure–activity relationship of indomethacin analogues for MRP-1, COX-1 and COX-2 inhibitionEuropean Journal of Cancer, 2002
- Loss of p53 Promotes Anaplasia and Local Invasion in ret/PTC1-Induced Thyroid CarcinomasThe American Journal of Pathology, 2000